DCAT (Drug Chemical and Associated Technologies Association) Revenue and Competitors

Robbinsville, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • DCAT (Drug Chemical and Associated Technologies Association)'s estimated annual revenue is currently $8.4M per year.(i)
  • DCAT (Drug Chemical and Associated Technologies Association)'s estimated revenue per employee is $201,000

Employee Data

  • DCAT (Drug Chemical and Associated Technologies Association) has 42 Employees.(i)
  • DCAT (Drug Chemical and Associated Technologies Association) grew their employee count by 27% last year.

DCAT (Drug Chemical and Associated Technologies Association)'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is DCAT (Drug Chemical and Associated Technologies Association)?

The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing. For more information about DCAT or to become a member, please visit our website at https://www.dcat.org.

keywords:N/A

N/A

Total Funding

42

Number of Employees

$8.4M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.5M680%N/A
#2
$18.6M9224%N/A
#3
$15.1M10411%N/A
#4
$31.9M110-2%N/A
#5
$16.5M1107%N/A